Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis.

Prenatal diagnosis - 1 Oct 2015

Hill Melissa, Twiss Philip, Verhoef Talitha I, Drury Suzanne, McKay Fiona, Mason Sarah, Jenkins Lucy, Morris Stephen, Chitty Lyn S

Abstract excerpt

OBJECTIVES: We aim to develop non-invasive prenatal diagnosis (NIPD) for cystic fibrosis (CF) and determine costs and implications for implementation. METHODS: A next-generation sequencing assay was developed to detect ten common CF mutations for exclusion of the paternal mutation in maternal plasma. Using uptake data from a study exploring views on NIPD for CF, total test-related costs were estimated for the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Costs and Cost Analysis
Share to Cystic Fibrosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cystic Fibrosis Research Advances

Share to Genetic Carrier Screening

Share to Genomics and Rare Diseases

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Prenatal Screening and Diagnostics

Source

Open in PubMed Open full text

Identifiers

PMID: 25708280
DOI: 10.1002/pd.4585
PMCID: PMC4672687

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis.PMID 25708280Read ↗

Noninvasive Prenatal Diagnosis for Cystic Fibrosis: Implementation, Uptake, Outcome, and ImplicationsSemantic proximity Read ↗

Genetic counseling access for parents of newborns who screen positive for cystic fibrosis: Consensus guidelinesSemantic proximity Read ↗

Improving genetic counseling access for parents of newborns who screen positive for cystic fibrosis: consensus guidelinesSemantic proximity Read ↗

Carrier Screening for Cystic FibrosisSemantic proximity Read ↗

A cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosisSemantic proximity Read ↗

Non‐invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathwaysSemantic proximity Read ↗

Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors.Semantic proximity Read ↗

Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis.Semantic proximity Read ↗

Sequencing as a first-line methodology for cystic fibrosis carrier screeningSemantic proximity Read ↗

Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors.Semantic proximity Read ↗

Genetic profiling enhances cystic fibrosis prenatal diagnosis.Semantic proximity Read ↗

REFINEMENT OF NEWBORN SCREENING FOR CYSTIC FIBROSIS WITH NEXT GENERATION SEQUENCINGSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.